Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by quest13on Jun 29, 2015 5:18pm
97 Views
Post# 23878737

RE:RE:RE:RE:RE:RE:RE:RE:RE:COULD NOT ZENITH DO THIS??

RE:RE:RE:RE:RE:RE:RE:RE:RE:COULD NOT ZENITH DO THIS??JK 

I WILL COMMENT AND I WILL USE ALL CAPS TO HELP YOU READ THIS DESPITE YOUR LOW VISION PROBLEMS.

FIRST OF ALL i HAVE NEVER SEEN A COMPANY WHICH DOES NOT HAVE AN EMPLOYMENT CONTRACT WHICH SPECIFIES QUITE CLEARLY THAT ANY WORK DONE WHICH GIVES RISE TO  PATENTABLE IP IS AGREED TO BE THE PROPERTY OF THE EMPLOYER AND NOT THE EMPLOYEE. THUS THE EMPLOYEE DOES NOT HAVE THE RIGHT TO PATENT SOMETHING IN HIS OWN NAME AND TRANSFER RIGHTS TO IT TO SOMEONE NOT HIS EM[PLOYER. THE ABSENCE OF SUCH CONTRACT RIGHTS AND OBLIGATIONS IS IN MY OPINION A BIG FAILURE ON THE PART OF MANAGEMENT. i OF COURSE HAVE NO KNOWLEDGE OF THE SPECIFIC SITUATION AND AM JUST SPECULATING.

ON THE SUBJECT OF BANKRUPTCY OR INSOLVANCY THE MAJOR DETERMINING FACTOR IS THAT A PERSON OR CORPORATION FAILS TO MEET HIS OBLIGATIONS AS THEY COME DUE.

THAT DOES NOT MEAN THAT A CREDITOR CANNOT RELAX THE TIMEFRAME OF THE OBLIGATION SO THAT THE DUE DATE IS DEFERRED. IN FACT IT IS QUITE COMMON THAT CREDITORS WILL RELAX AND DEFER THE PAYMENTS SO THAT IN FACT THEY HAVE NOT COME DUE TO GIVE APPROPRIATE BREATHING SPACE TO DEBTORS AND IN PARTICULAR WHEN SOMEONE NEEDS MORE TIME AND HAS REASONABLE PROSPECTS OF BEING ABLE TO PAY IF GIVEN TIME. A SPECIFIC SITUATION IS HERE IN THE CASE WE HAVE BEEN TALKING ABOUT WHERE THE COMPANY COULD RAISE FUNDS BY A PLACEMENT OF SHARES, AND THE ISSUE IS WHAT IS THE BEST SITUATION OVERALL.

OF COURSE BANKS HOLDING MORTGAGES OF PRIVATE INDIVIDUALS TEND TO BE HARD HEARTED BUT EVEN THEY HAVE BEEN KNOWN TO DELAY OR DEFER MORTGAGE PAYMENTS IN CASES WHERE FOR EXAMPLE AN EMLOYEE SEES HIS EMPLOYER CLOSE DOWN A COMPANY BUT IT IS REASONABLE THAT THE EMPLOYEE WILL FIND A NEW JOB AND BE ABLE TO RESTART MAKING PAYMENTS IN WHAT THE BANK CONSIDERS A REASONABLE TIMEFRAME RATHER THAN FORECLOSE
Bullboard Posts